Comparison of the upfront surgery and neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: an updated systematic review and meta-analysis.

Yang, Si-Qi; Zou, Rui-Qi; Dai, Yu-Shi; Li, Fu-Yu; Hu, Hai-Jie

Yang, Si-Qi; Zou, Rui-Qi; Dai, Yu-Shi; Li, Fu-Yu; Hu, Hai-Jie.

Affiliation

Yang SQ; Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Zou RQ; Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Dai YS; Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Li FY; Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. lfy_74@hotmail.com.
Hu HJ; Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. hhj1063557621@163.com.

Updates Surg ; 76(1): 1-15, 2024 Jan.

Article in En | MEDLINE | ID: mdl-37639177

Subject(s)

Adenocarcinoma; Pancreatic Neoplasms; Humans; Neoadjuvant Therapy/methods; Pancreatic Neoplasms/drug therapy; Pancreatic Neoplasms/surgery; Combined Modality Therapy; Prognosis

Key words

Neoadjuvant therapy; Pancreatic cancer; Survival; Upfront surgery

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Updates Surg Year: 2024 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google